DOI:
10.1055/s-00000125
Senologie - Zeitschrift für Mammadiagnostik und -therapie
LinksClose Window
References
Mobus V, Jackisch C, Luck HJ. et al.
Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.
Ann Oncol 2018;
29: 178-185
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.